Immunovant, Inc.

About Immunovant, Inc.

Immunovant, Inc. is dedicated to enabling normal lives for people with autoimmune diseases by applying a patient-focused approach to advance treatments tailored to the complex and variable needs of these individuals across different disease stages and severities.

Products & Services

Pipeline & Therapeutic Areas:Focused on developing treatments for autoimmune diseases, with details available in their pipeline overview.

Specialties

Autoimmune Disease Treatments Patient-Focused Therapeutic Development FcRn Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Common Stock Offering T: - FT: Common Stock Offering	A: 550000000 MR: - FA: $550 million FAN: 550000000	D: 2025-12-11 FD: 2025-12-11	2 investors
2	RT: PIPE T: - FT: PIPE	A: 450000000 MR: - FA: $450 million FAN: 450000000	D: 2025-01-13 FD: 2025-01-13	3 investors
3	RT: Private Placement T: - FT: Private Placement	A: 337900200 MR: - FA: 337,900,200 USD FAN: 337900200	D: 2025-01-13 FD: 2025-01-13	1 investors
4	RT: Public Offering T: - FT: Public Offering	A: 492100000 MR: - FA: approximately $492.1 million FAN: 492100000	D: 2023-10-02 FD: 2023-10-02	6 investors

Common Stock Offering Latest

2025-12-11

$550.0M

2 investors (Pro only)

PIPE 2025-01-13

$450.0M

Private Placement 2025-01-13

$337.9M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eric Venker

Chief Executive Officer

C

Christine Blodgett

Senior Vice President of Human Resources

A

Andy Deig

Senior Vice President Strategic Finance

K

Khira Gabliani

Chief of Staff to the CEO

M

Michael Geffner

Chief Medical Officer

T

Tiago Girão

Chief Financial Officer

View 43 more team members with Pro

Unlock Full Team Directory

Recent News

Immunovant, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised